Plasma proGRP Concentration is Sensitive and Specific for Discriminating Small Cell Lung Cancer from Nonmalignant Conditions or Non-small Cell Lung Cancer

To date, most clinical data on pro-gastrin-releasing peptide (proGRP) have been based on serum concentrations. This study evaluated the agreement between proGRP levels in fresh serum and plasma in patients with various lung diseases. Pairs of serum and EDTA plasma were collected from 49 healthy indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye-Ran, Oh, In-Jae, Shin, Myung-Geun, Park, Joon-Seok, Choi, Hyun-Jung, Ban, Hee-Jung, Kim, Kyu-Sik, Kim, Young-Chul, Shin, Jong-Hee, Ryang, Dong-Wook, Suh, Soon-Pal
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082113/
https://www.ncbi.nlm.nih.gov/pubmed/21532852
http://dx.doi.org/10.3346/jkms.2011.26.5.625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082113/
https://www.ncbi.nlm.nih.gov/pubmed/21532852
http://dx.doi.org/10.3346/jkms.2011.26.5.625

Ejemplares similares